Search
for
Sort by
Research 211–240 of 1000+
- Prevalence of Cutaneous Disorders in Patients with Polycystic Ovary Syndrome
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Comparison of Zn, Cu, and Fe Content in Hair and Serum in Alopecia Areata Patients with Normal Group
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study
- Illness Perception, Emotional Distress, and Obsessive–Compulsive Symptomatology in Patients with Alopecia Areata: A Mediation Study
- Family-related quality of life and burden in caregivers of patients with chronic skin diseases
- Features of hemorheological disorders in patients with alopecia associated with coronavirus infection
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
- Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- SMART Pharmacists Serving the New Needs of the Post-COVID Patients, Leaving No-One Behind
- Impact of anticancer therapy on the quality of life of Sudanese patients with breast cancer at Khartoum oncology hospital
- Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa: A single institution, real-world cohort study
- A New Method for the Follow-Up of Patients with Alopecia Areata
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome
- The effects of low-dose radiation therapy in patients with mild-to-moderate Alzheimer's dementia: an interim analysis of a pilot study
- Time Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome
- Improving knowledge of hair loss disorders: Assessing the efficacy of a dermatologist-developed social media video library for patient education
- Scalp cooling versus standard cold-cap in preventing chemotherapy-induced alopecia in patients with localized breast cancer: ICELAND protocol, a randomized controlled trial and economic evaluation
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care